The antibacterial and antiviral mask products on the market are currently only in the research and development stage of many companies, because the National Health Commission and the State Food and Drug Administration have not conducted research on the product safety and product effectiveness. Demonstration, so this product is not currently on the market.
With the development of the new coronavirus epidemic, many supplies are now allowed to be purchased and used by the public. For example, the recently popular new coronavirus testing reagents are allowed to be purchased by individuals. This is a good example. Regarding the production of antibacterial and antiviral masks, the State Food and Drug Administration stated that it will organize relevant experts to conduct demonstrations on many aspects of the masks. Only after the demonstration is passed, specific manufacturers will be allowed to produce them. It is normal for antibacterial and antiviral mask products to need demonstration, because antibacterial and antiviral masks use antibacterial agents after all. The key is how much antibacterial agent to use and how to ensure that the antibacterial agent does not cause safety production problems during the production process.
Current status 1: This product is still in the demonstration stage
This product is still in the demonstration stage, and many manufacturers have not yet started producing this mask. After all, the State Food and Drug Administration has not There are no corresponding standards for the production and sales of this mask. In terms of product effectiveness, it is difficult to say whether the product has a more effective protective effect and whether it can effectively filter external bacteria and readable substances. In terms of product safety, due to the use of a new substance called antibacterial agents, this also leads to the question of what dose of antibacterial agents is harmless to the human body and how to combine antibacterial agents with textile production during the production process to ensure safe production. became a key issue. Only when the product effectiveness and product safety of antibacterial and antiviral masks have been demonstrated and standards established can pharmaceutical companies be able to put the product on the market.
Current situation 2: This product has great market prospects
If antibacterial and antiviral masks are effective, they still have great development prospects. Now that the new crown epidemic is further developing, if this The protective effect of masks is better than any previous medical masks, and there are no major safety issues in the production process. This will not only stimulate consumers to be more willing to buy such masks, but also stimulate pharmaceutical companies to make more money. money to produce such masks. In terms of these two aspects, the development of antibacterial and antiviral mask products has a huge market.